Journal of Cancer Therapy

Vol.8 No.11(2017), Paper ID 80346, 8 pages

DOI:10.4236/jct.2017.811082

 

Impressive Objective Response to Nab-Paclitaxel plus Trastuzumab as Fifth Line Therapy in an Elderly HER-2 Positive Breast Cancer Patient

 

Maria Rosaria Valerio, Chiara Ancona, Antonella Marchese, Vittorio Gebbia

 

Medical Oncology Unit, Department of Oncology, University of Palermo, Palermo, Italy
Medical Oncology Unit, Department of Oncology, University of Palermo, Palermo, Italy
Medical Oncology Unit, La Maddalena Clinic for Cancer, University of Palermo, Palermo, Italy
Medical Oncology Unit, La Maddalena Clinic for Cancer, University of Palermo, Palermo, Italy

 

Copyright © 2017 Maria Rosaria Valerio, Chiara Ancona, Antonella Marchese, Vittorio Gebbia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Valerio, M. , Ancona, C. , Marchese, A. and Gebbia, V. (2017) Impressive Objective Response to Nab-Paclitaxel plus Trastuzumab as Fifth Line Therapy in an Elderly HER-2 Positive Breast Cancer Patient. Journal of Cancer Therapy, 8, 933-940. doi: 10.4236/jct.2017.811082.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.